AAAAAA

   
Results: 1-23 |
Results: 23
DIFFERENTIAL-EFFECTS OF PRAVASTATIN, SIMVASTATIN AND ATORVASTATIN ON VASCULAR REACTIVITY
Authors: TESFAMARJAM B FROHLICH BH GREGG RE
Citation: B. Tesfamarjam et al., DIFFERENTIAL-EFFECTS OF PRAVASTATIN, SIMVASTATIN AND ATORVASTATIN ON VASCULAR REACTIVITY, The FASEB journal, 12(5), 1998, pp. 4099-4099
AN MTP INHIBITOR THAT NORMALIZES ATHEROGENIC LIPOPROTEIN LEVELS IN WHHL RABBITS
Authors: WETTERAU JR GREGG RE HARRITY TW ARBEENY C CAP M CONNOLLY F CHU CH GEORGE RJ GORDON DA JAMIL H JOLIBOIS KG KUNSELMAN LK LAN SJ MACCAGNAN TJ RICCI B YAN MJ YOUNG D CHEN Y FRYSZMAN OM LOGAN JVH MUSIAL CL POSS MA ROBL JA SIMPKINS LM SLUSARCHYK WA SULSKY R TAUNK P MAGNIN DR TINO JA LAWRENCE RM DICKSON JK BILLER SA
Citation: Jr. Wetterau et al., AN MTP INHIBITOR THAT NORMALIZES ATHEROGENIC LIPOPROTEIN LEVELS IN WHHL RABBITS, Science, 282(5389), 1998, pp. 751-754
UP-REGULATED SYNTHESIS OF BOTH APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B IN FAMILIAL HYPERALPHALIPOPROTEINEMIA AND HYPERBETALIPOPROTEINEMIA
Authors: SCHMIDT HHJ GREGG RE TIETGE UJF BEISIEGEL U ZECH LA BREWER HB MANNS MP BOJANOVSKI D
Citation: Hhj. Schmidt et al., UP-REGULATED SYNTHESIS OF BOTH APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B IN FAMILIAL HYPERALPHALIPOPROTEINEMIA AND HYPERBETALIPOPROTEINEMIA, Metabolism, clinical and experimental, 47(9), 1998, pp. 1160-1166
EVIDENCE THAT MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN IS LIMITING INTHE PRODUCTION OF APOLIPOPROTEIN B-CONTAINING LIPOPROTEINS IN HEPATICCELLS
Authors: JAMIL H CHU CH DICKSON JK CHEN Y YAN MJ BILLER SA GREGG RE WETTERAU JR GORDON DA
Citation: H. Jamil et al., EVIDENCE THAT MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN IS LIMITING INTHE PRODUCTION OF APOLIPOPROTEIN B-CONTAINING LIPOPROTEINS IN HEPATICCELLS, Journal of lipid research, 39(7), 1998, pp. 1448-1454
IN-MEMORIAM - HOEG,JEFFREY,M., MD - 1952-1998
Authors: BROUSSEAU ME GREGG RE SCHAEFER EJ
Citation: Me. Brousseau et al., IN-MEMORIAM - HOEG,JEFFREY,M., MD - 1952-1998, Journal of lipid research, 39(10), 1998, pp. 2107-2107
INTROGRESSIVE HYBRIDIZATION OF TILAPIAS IN ZIMBABWE
Authors: GREGG RE HOWARD JH SHONHIWA F
Citation: Re. Gregg et al., INTROGRESSIVE HYBRIDIZATION OF TILAPIAS IN ZIMBABWE, Journal of Fish Biology, 52(1), 1998, pp. 1-10
RECOMMENDATIONS FOR PHASE-IV STUDIES IN THE DEVELOPMENT OF LIPID-LOWERING DRUGS
Authors: GREGG RE
Citation: Re. Gregg, RECOMMENDATIONS FOR PHASE-IV STUDIES IN THE DEVELOPMENT OF LIPID-LOWERING DRUGS, The American journal of cardiology, 81(8A), 1998, pp. 64-65
WILL GENETICS REALLY REVOLUTIONIZE THE DRUG DISCOVERY PROCESS
Authors: GELBERT LM GREGG RE
Citation: Lm. Gelbert et Re. Gregg, WILL GENETICS REALLY REVOLUTIONIZE THE DRUG DISCOVERY PROCESS, Current opinion in biotechnology, 8(6), 1997, pp. 669-674
INHIBITION OF CHOLESTEROL-SYNTHESIS BY SQUALENE SYNTHASE INHIBITORS DOES NOT INDUCE MYOTOXICITY IN-VITRO
Authors: FLINT OP MASTERS BA GREGG RE DURHAM SK
Citation: Op. Flint et al., INHIBITION OF CHOLESTEROL-SYNTHESIS BY SQUALENE SYNTHASE INHIBITORS DOES NOT INDUCE MYOTOXICITY IN-VITRO, Toxicology and applied pharmacology, 145(1), 1997, pp. 91-98
HMG COA REDUCTASE INHIBITOR-INDUCED MYOTOXICITY - PRAVASTATIN AND LOVASTATIN INHIBIT THE GERANYLGERANYLATION OF LOW-MOLECULAR-WEIGHT PROTEINS IN NEONATAL RAT MUSCLE-CELL CULTURE
Authors: FLINT OP MASTERS BA GREGG RE DURHAM SK
Citation: Op. Flint et al., HMG COA REDUCTASE INHIBITOR-INDUCED MYOTOXICITY - PRAVASTATIN AND LOVASTATIN INHIBIT THE GERANYLGERANYLATION OF LOW-MOLECULAR-WEIGHT PROTEINS IN NEONATAL RAT MUSCLE-CELL CULTURE, Toxicology and applied pharmacology, 145(1), 1997, pp. 99-110
ERDHEIM-CHESTER-DISEASE - LOW LOW-DENSITY-LIPOPROTEIN LEVELS DUE TO RAPID CATABOLISM
Authors: SCHMIDT HHJ GREGG RE SHAMBUREK R BREWER BHB ZECH LA
Citation: Hhj. Schmidt et al., ERDHEIM-CHESTER-DISEASE - LOW LOW-DENSITY-LIPOPROTEIN LEVELS DUE TO RAPID CATABOLISM, Metabolism, clinical and experimental, 46(10), 1997, pp. 1215-1219
AN INHIBITOR OF THE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN INHIBITSAPO-B SECRETION FROM HEPG2 CELLS
Authors: JAMIL H GORDON DA EUSTICE DC BROOKS CM DICKSON JK CHEN Y RICCI B CHU CH HARRITY TW CIOSEK CP BILLER SA GREGG RE WETTERAU JR
Citation: H. Jamil et al., AN INHIBITOR OF THE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN INHIBITSAPO-B SECRETION FROM HEPG2 CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 93(21), 1996, pp. 11991-11995
ORALLY-ACTIVE SQUALENE SYNTHASE INHIBITORS - BIS((ACYLOXY)ALKYL) PRODRUGS OF THE ALPHA-PHOSPHONOSULFONIC ACID MOIETY
Authors: DICKSON JK BILLER SA MAGNIN DR PETRILLO EW HILLYER JW HSIEH DC LAN SJ RINEHART JK GREGG RE HARRITY TW JOLIBOIS KG KALINOWSKI SS KUNSELMAN LK MOOKHTIAR KA CIOSEK CP
Citation: Jk. Dickson et al., ORALLY-ACTIVE SQUALENE SYNTHASE INHIBITORS - BIS((ACYLOXY)ALKYL) PRODRUGS OF THE ALPHA-PHOSPHONOSULFONIC ACID MOIETY, Journal of medicinal chemistry, 39(3), 1996, pp. 661-664
INHIBITION OF THE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN BLOCKS THEFIRST STEP OF APOLIPOPROTEIN-B LIPOPROTEIN ASSEMBLY BUT NOT THE ADDITION OF BULK CORE LIPIDS IN THE 2ND STEP
Authors: GORDON DA JAMIL H GREGG RE OLOFSSON SO BOREN J
Citation: Da. Gordon et al., INHIBITION OF THE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN BLOCKS THEFIRST STEP OF APOLIPOPROTEIN-B LIPOPROTEIN ASSEMBLY BUT NOT THE ADDITION OF BULK CORE LIPIDS IN THE 2ND STEP, The Journal of biological chemistry, 271(51), 1996, pp. 33047-33053
IN-VITRO MYOTOXICITY OF THE 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE INHIBITORS, PRAVASTATIN, LOVASTATIN, AND SIMVASTATIN, USING NEONATAL RAT SKELETAL MYOCYTES
Authors: MASTERS BA PALMOSKI MJ FLINT OP GREGG RE WANGIVERSON D DURHAM SK
Citation: Ba. Masters et al., IN-VITRO MYOTOXICITY OF THE 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE INHIBITORS, PRAVASTATIN, LOVASTATIN, AND SIMVASTATIN, USING NEONATAL RAT SKELETAL MYOCYTES, Toxicology and applied pharmacology, 131(1), 1995, pp. 163-174
DOMINANT EXPRESSION OF TYPE-III HYPERLIPOPROTEINEMIA - PATHOPHYSIOLOGICAL INSIGHTS DERIVED FROM THE STRUCTURAL AND KINETIC CHARACTERISTICS OF APOE-1(LYS(146)-]GLU)
Authors: MANN WA LOHSE P GREGG RE RONAN R HOEG JM ZECH LA BREWER HB
Citation: Wa. Mann et al., DOMINANT EXPRESSION OF TYPE-III HYPERLIPOPROTEINEMIA - PATHOPHYSIOLOGICAL INSIGHTS DERIVED FROM THE STRUCTURAL AND KINETIC CHARACTERISTICS OF APOE-1(LYS(146)-]GLU), The Journal of clinical investigation, 96(2), 1995, pp. 1100-1107
A 30-AMINO ACID TRUNCATION OF THE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN LARGE SUBUNIT DISRUPTS ITS INTERACTION WITH PROTEIN DISULFIDE-ISOMERASE AND CAUSES ABETALIPOPROTEINEMIA
Authors: RICCI B SHARP D OROURKE E KIENZLE B BLINDERMAN L GORDON D SMITHMONROY C ROBINSON G GREGG RE RADER DJ WETTERAU JR
Citation: B. Ricci et al., A 30-AMINO ACID TRUNCATION OF THE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN LARGE SUBUNIT DISRUPTS ITS INTERACTION WITH PROTEIN DISULFIDE-ISOMERASE AND CAUSES ABETALIPOPROTEINEMIA, The Journal of biological chemistry, 270(24), 1995, pp. 14281-14285
MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN - SPECIFICITY OF LIPID-BINDING AND TRANSPORT
Authors: JAMIL H DICKSON JK CHU CH LAGO MW RINEHART JK BILLER SA GREGG RE WETTERAU JR
Citation: H. Jamil et al., MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN - SPECIFICITY OF LIPID-BINDING AND TRANSPORT, The Journal of biological chemistry, 270(12), 1995, pp. 6549-6554
BMS-188494, AN ORALLY-ACTIVE SQUALENE SYNTHASE INHIBITOR PRODRUG, POTENTLY LOWERS PLASMA-CHOLESTEROL AND TRIGLYCERIDES IN RATS, HAMSTERS AND PRIMATES
Authors: HARRITY TW GEORGE RJ CIOSEK CP BILLER SA CHEN Y DICKSON JK FRYSZMAN OM JOLIBOIS KJ KUNSELMAN LK LAWRENCE RM LOGAN JV MAGNIN DR RICH LC SLUSARCHYK DA SULSKY RB GREGG RE
Citation: Tw. Harrity et al., BMS-188494, AN ORALLY-ACTIVE SQUALENE SYNTHASE INHIBITOR PRODRUG, POTENTLY LOWERS PLASMA-CHOLESTEROL AND TRIGLYCERIDES IN RATS, HAMSTERS AND PRIMATES, Circulation, 92(8), 1995, pp. 484-484
MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN IS LIMITING IN THE ASSEMBLY AND SECRETION OF APO-B CONTAINING LIPOPROTEINS IN HEPG2 AND MCARDLE RH-7777 CELL-LINES
Authors: JAMIL H CHU CH CHEN Y DICKSON JK BILLER SA GREGG RE WETTERAU JR GORDON DA
Citation: H. Jamil et al., MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN IS LIMITING IN THE ASSEMBLY AND SECRETION OF APO-B CONTAINING LIPOPROTEINS IN HEPG2 AND MCARDLE RH-7777 CELL-LINES, Circulation, 92(8), 1995, pp. 1717-1717
SECRETION OF APOLIPOPROTEIN B-CONTAINING LIPOPROTEINS FROM HELA-CELLSIS DEPENDENT ON EXPRESSION OF THE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND IS REGULATED BY LIPID AVAILABILITY
Authors: GORDON DA JAMIL H SHARP D MULLANEY D YAO ZM GREGG RE WETTERAU J
Citation: Da. Gordon et al., SECRETION OF APOLIPOPROTEIN B-CONTAINING LIPOPROTEINS FROM HELA-CELLSIS DEPENDENT ON EXPRESSION OF THE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND IS REGULATED BY LIPID AVAILABILITY, Proceedings of the National Academy of Sciences of the United Statesof America, 91(16), 1994, pp. 7628-7632
CLONING AND GENE DEFECTS IN MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN ASSOCIATED WITH ABETALIPOPROTEINEMIA
Authors: SHARP D BLINDERMAN L COMBS KA KIENZLE B RICCI B WAGERSMITH K GIL CM TURCK CW BOUMA ME RADER DJ AGGERBECK LP GREGG RE GORDON DA WETTERAU JR
Citation: D. Sharp et al., CLONING AND GENE DEFECTS IN MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN ASSOCIATED WITH ABETALIPOPROTEINEMIA, Nature, 365(6441), 1993, pp. 65-69
INVIVO METABOLISM OF A MUTANT FORM OF APOLIPOPROTEIN A-I, APO A-I(MILANO), ASSOCIATED WITH FAMILIAL HYPOALPHALIPOPROTEINEMIA
Authors: ROMA P GREGG RE MENG MS RONAN R ZECH LA FRANCESCHINI G SIRTORI CR BREWER HB
Citation: P. Roma et al., INVIVO METABOLISM OF A MUTANT FORM OF APOLIPOPROTEIN A-I, APO A-I(MILANO), ASSOCIATED WITH FAMILIAL HYPOALPHALIPOPROTEINEMIA, The Journal of clinical investigation, 91(4), 1993, pp. 1445-1452
Risultati: 1-23 |